GIM
GH icon

Glenmede Investment Management’s Guardant Health GH Stock Holding History

Glenmede Investment Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$283K Buy
4,529
+475
+12% +$25.8K ﹤0.01% 1136
2025
Q2 		$211K Buy
+4,054
New +$181K ﹤0.01% 1216

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Glenmede Investment Management's GH Position: Q3 2025 in Review

Glenmede Investment Management increased its Guardant Health (GH) stake by 12% in Q3 2025, buying an estimated $25.8K and bringing the position to 4,529 shares worth $283K. The position accounts for ﹤0.01% of the portfolio, ranked #1136.

Glenmede Investment Management first reported a position in GH in Q2 2025 and has held it in 2 quarters since. 395 funds tracked by Wall St. Rank hold GH as of Q3 2025.

  • Glenmede Investment Management held 4,529 shares of Guardant Health worth $283K as of Q3 2025.
  • Glenmede Investment Management bought 475 Guardant Health shares in Q3 2025, an estimated $25.8K.
  • Guardant Health made up ﹤0.01% of Glenmede Investment Management's portfolio in Q3 2025, its #1136 holding.
  • Glenmede Investment Management first reported a position in Guardant Health in Q2 2025 and has held it in 2 quarters since.
  • 395 funds tracked by Wall St. Rank held Guardant Health as of Q3 2025.

Based on Glenmede Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.